Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Questor trust bargains: North Atlantic Smaller Companies is available at a 29pc discount
With UK smaller companies coming back into favour after a long period on the sidelines, it is time this column looked at a fund with a strong and long track record in this corner of the stock market.
North Atlantic Smaller Companies is a £555m investment trust run by chief executive and fund manager Christopher Mills since 1982. As its name suggests, it takes an Anglo-American approach to investing in “small cap” stocks with nearly 10pc of assets in US businesses, although more than three quarters is held in UK companies.
Mr Mills, 71, who is also founder and chief executive of investment group Harwood Capital, is best known as an activist investor, although he prefers to use the word “engaged” to describe his approach of buying big stakes in companies and joining their boards to help managements turn around or restructure businesses.
Whatever one calls it, Mr Mills’ robust defence of shareholder returns has proved successful. Shareholders in Hipgnosis Songs, where he had no stake, should be delighted he was recruited to the music royalty fund’s board last year as he was instrumental in securing its sale to US investment giant Blackstone and salvaging a decent return for investors after several years of poor performance.
The results of his deal-making are best shown in the way North Atlantic Smaller Companies has consistently beaten the returns of the UK stock market. According to the company, at 30 June his 42-year tenure had seen Mills generate a 13pc annualised return from the trust’s investments, exceeding the 8.9pc annual return from the FTSE All-Share index.
Its underlying investment growth has also outperformed the UK benchmark over five, 10, 20 and 30 years, although annual returns have fallen to an average of 6.7pc since 2019.
Despite the shares trading 29pc below the net asset value of the trust’s investments, shareholders have done well with a ten-year total return including annual dividends of 147.5pc. That easily beats the 61.2pc return from the Deutsche Numis Smaller Companies index.
As with its UK small-cap rivals, the past three years have been difficult ones, with the shares down 8pc as investors spurned domestic stocks worried about the impact of high interest rates and inflation.
The past 12 months have witnessed a recovery, however, with the shares rallying 19pc, helped by the strong performance of Oryx International Growth, a £202m investment trust that Mr Mills also runs with his son Nicholas, in which 17.7pc of North Atlantic’s assets are invested. (North Atlantic also holds 3.7pc in Odyssean, another UK small-cap investment trust in the Harwood stable which we tipped in June 2022.)
Oryx also invests in smaller companies but largely eschews stakes in private businesses with less than 5pc in unlisted stocks compared to the 20pc held by North Atlantic, mostly through Harwood Capital’s private equity funds.
Unburdened by the negative sentiment to unquoted stocks, Oryx has generated a highly impressive 259pc shareholder return over 10 years but is more volatile and harder to buy into on account of North Atlantic owning over half its stock.
Turning back to North Atlantic, improved trading in five of its biggest quoted companies, which account for nearly 21pc of the £751m portfolio, has also helped recent returns. Fund manager Polar Capital Holdings, asthma treatment provider Niox and housebuilder MJ Gleeson have recently issued positive updates.
Half-year results next month could see Mr Mills elaborate on his plans for a cash pile that has swollen to £100m from returns of capital and special dividends by companies.
There should also be news on the disposals of three private equity businesses, including two from the US: Performance Chemicals, a supplier to the oil and gas industry; and aviation caterer Jaguar Holdings. In May Mills also anticipated a good profit on the sale of a 30pc stake in Spring Investments, a UK drugs supplier to the NHS.
Unfortunately, the updates Mr Mills provides are not as frequent or as detailed as other fund managers, although North Atlantic has pledged to improve transparency. We look forward to that as it should encourage investors and help narrow the shares’ wide discount.
In the meantime, we take comfort that Peter Spiller, the manager of Capital Gearing Trust, a longstanding Questor tip, is a big fan. Mr Spiller, who pips Mills to the post as the UK’s longest-serving fund manager, holds him in high regard and owns 6.8pc of North Atlantic.
With small companies rallying on a strengthening UK economy, that’s a powerful endorsement.
Questor says: buyTicker: NASClosing price: £40.80
Gavin Lumsden is editor of Citywire’s Investment Trust Insider website.
Read the latest Questor column on telegraph.co.uk every Tuesday, Wednesday, Thursday and Friday from 6am.
Read Questor’s rules of investment before you follow our tips.